Cancer Treatment: Biocompatible, Uniform, and Redispersible Mesoporous Silica Nanoparticles for Cancer‐Targeted Drug Delivery In Vivo (Adv. Funct. Mater. 17/2014)

Y. L. Zhao and colleagues develop biocompatible, uniform, and redispersible mesoporous silica nanoparticle-based nanocarriers towards controlled and cancer-targeted drug delivery for significantly inhibiting the tumor growth in vivo. On page 2450, the research team demonstrates a successful cancer therapy protocol of 1) intravenous injection of drug-loaded nanocarriers, 2) controlled and targeted drug delivery to tumor sites for therapy, and 3) excretion of the nanocarriers from the animal bodies after the drug delivery.